US Patent 8933052 Uracyl spirooxetane nucleosides

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8933052

Date of Patent

January 13, 2015

Patent Application Number

13836465

Date Filed

March 15, 2013

Patent Citations Received

‌

US Patent 12084473 β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

‌

US Patent 11707480 Highly active compounds against COVID-19

‌

US Patent 11975016 2′-substituted-N

‌

US Patent 12006340 Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus

Patent Primary Examiner

‌

Traviss C Mcintosh, III

Patent abstract

Compounds of the formula I:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8933052 Uracyl spirooxetane nucleosides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API